Vilde Drageset Haakensen

Treatment Characteristics and Real-World Progression-Free Survival in Patients With Unresectable Stage III NSCLC Who Received Durvalumab After Chemoradiotherapy: Findings From the PACIFIC-R Study

Nicolas Girard, Jair Bar, Pilar Garrido et al. · Journal of Thoracic Oncology · 2022 · 226 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Genome-wide DNA methylation profiles in progression to in situand invasive carcinoma of the breast with impact on gene transcription and prognosis

Thomas Fleischer, Arnoldo Frigessi, Kevin C. Johnson et al. · Genome biology · 2014 · 179 citations · Full text

Medicine, Molecular Biology, Oncology +17

Association of N-Glycosylation with Breast Carcinoma and Systemic Features Using High-Resolution Quantitative UPLC

Radka Saldova, Akram Asadi Shehni, Vilde Drageset Haakensen et al. · Journal of Proteome Research · 2014 · 146 citations · Full text

Life Sciences, Biochemistry, Oncology +17

Integrated molecular profiles of invasive breast tumors and ductal carcinoma in situ (DCIS) reveal differential vascular and interleukin signaling

Vessela N. Kristensen, Charles Vaske, Josie Ursini‐Siegel et al. · Proceedings of the National Academy of Sciences · 2011 · 143 citations · Full text

Medicine, Cancer Biology, Oncology +17

Proteogenomics of non-small cell lung cancer reveals molecular subtypes associated with specific therapeutic targets and immune-evasion mechanisms

Janne Lehtiö, Taner Arslan, Ioannis Siavelis et al. · Nature Cancer · 2021 · 116 citations · Full text

Medicine, Molecular Biology, Oncology +14